1 We noted 11% lower all-cause mortality and 16% lower CVD mort
2 In particular,
we noted a 24.3-fold increase in phosphorus (P) flux between
3 We noted a high level of Cavin-2 expression in the neovascula
4 We noted a marked association of sCD23 with chronic lymphocyt
5 Additionally,
we noted a profoundly significant increase in taxa from Prote
6 Relating these findings to the human setting,
we noted a reduction in SIRT1 mRNA in kidney biopsies obtaine
7 We noted a small reduction (median -7.7% [IQR -21.6 to 6.8])
8 With all other variables held constant,
we noted a steady average increase in eGFR until donors reach
9 In AIH/AISC
we noted a substantial increase in peripheral blood-derived C
10 We noted aggregation and colocalization of LPS with TCPs in s
11 We noted an alarming genetic relatedness between 7 (20.6%) MR
12 We noted an effect on the percentage of days abstinent in the
13 Between 1995 and 2014,
we noted an increase in excess life-years lost for neoplasms
14 In the absence of IL-1 signaling,
we noted an increase in the transcription of type I interfero
15 iver cytotoxic agents to infected or Env-transfected cells,
we noted disparities in their functional activities.
16 ly with antimony drug-sensitive and -resistant L. donovani,
we noted disruption in the steady-state level of Wnt5a.
17 INTERPRETATION: Although
we noted little differences in the levels of morbidity compre
18 Moreover,
we noted multiple modes of interaction between SERCA and phos
19 However,
we noted no changes in either group in invasive pneumococcal
20 However,
we noted no changes in rCBF and flux in presymptomatic carrie
21 We noted no difference in progression-free survival between s
22 We noted no difference in survival between patients who were
23 We noted no effect on disease activity indices or other psych
24 in the EUC plus CAP group than in the EUC alone group, but
we noted no effect on mean daily alcohol consumed in the past
25 We noted no significant difference in intra-arterial treatmen
26 We noted no significant difference in the number of serious a
27 We noted no significant differences between statin users and
28 INTERPRETATION:
We noted no survival benefit in men with metastatic castratio
29 We noted secular improvements in all postnatal growth paramet
30 We noted signficant accumulation of 3-3 crosslinked muropepti
31 Over 120 weeks,
we noted significant differences in the pooled analysis favou
32 We noted significant geographical variations in demographics,
33 Over the entire trial,
we noted significant worsening on tests of verbal memory (T s
34 cks Ldgp63 trafficking and secretion in Leishmania Finally,
we noted significantly compromised survival of LdSar1:T34N-GF
35 Controlling for various confounding factors,
we noted that annual mortality among oldest-old individuals w
36 In a Cox model,
we noted that districts with higher population densities also
37 We noted that GCs increase the transcription of several key r
38 We noted that inhibitory residues tethered within the NAD(+)-
39 Moreover,
we noted that Optn phosphorylation at Ser-177 was required fo
40 We noted that PllA specifically recognizes this epitope on th
41 We noted that the ATP/inhibitor-binding sites of the TAM memb
42 We noted that the closely linked E26 transformation-specific
43 We noted that the oxidized catalytic center contains a Cu(II)
44 tween paired primary and recurrent NPC from 95 patients and
we noted that there was significant increase in the expressio
45 We noted that these ICB antibodies rescued the levels of IFNg
46 In the treatment-resistant tumors
we noted the emergence of CD31-negative patent neovessels and
47 We noted the presence of abnormal Remak bundles with long SCs
48 We noted the substantial phenotypic overlap with individuals
49 We noted two loci shared with pulmonary fibrosis (FAM13A and
50 We noted unsatisfactory efficacy (ie, <80%) with clarithromyc